Get notified when TARS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTarsus Pharmaceuticals CCO Aziz Mottiwala departing July 15 for CEO role elsewhere
Filed July 13, 2026 · Period ending July 13, 2026 · ~1 min read
Key Changes
-
medium
Chief Commercial Officer Aziz Mottiwala leaving July 15, 2026 to become CEO of a public medical device company—a voluntary departure for career advancement, not termination or adverse circumstances.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NKE 10-K) is open in full — no account needed.
Partner
Trade TARS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 16, 2026 · How we verify